Researchers at the UK Health Security Agency and University of Oxford have identified the cause of the unusually severe meningitis B outbreak that affected young people in Kent earlier this year. The outbreak, centered around a nightclub in Canterbury, resulted in more than 20 infections among mostly students, with all cases requiring hospitalization. Nine individuals required intensive care treatment, and two people died.
The investigation into the bacterial DNA revealed that the responsible strain had acquired genetic material from other organisms naturally present in some people’s throats. This genetic exchange, known as horizontal gene transfer, created a new variant capable of causing particularly serious illness. The genetic modifications appear to have made the bacteria more virulent while potentially helping it evade immune system responses in individuals who had not previously encountered this particular strain.
Experts emphasize that the meningitis B vaccine currently being offered to university-bound young people provides protection against this outbreak strain. A vaccination program was initiated following the outbreak, with two doses recommended for optimal protection. First doses are available until 31 December 2026, while second doses can be administered until 31 March 2027. Vaccination appointments are available at pharmacies throughout England, including walk-in options.
Dr Charlene Rodrigues from UKHSA noted that the speed and severity of the Kent outbreak were highly unusual, describing the situation as unprecedented. The outbreak’s explosive nature was attributed partly to the social environment of the nightclub, where close mixing among large numbers of people facilitated rapid transmission. Interestingly, the same genetic changes that made the strain particularly dangerous may also explain why the outbreak remained contained and did not continue spreading more broadly, as infected individuals became too ill to serve as asymptomatic carriers.
Following the outbreak, public health advisers have recommended that the government consider introducing routine meningitis B vaccination for secondary school-aged children around age 15 to improve population protection against this potentially fatal disease.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI